$AKTSQ
Akoustis Technologies, Inc. Stock $aktsq

$aktsq Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-K Financial Statement

#000121390022055194 Filed on September 12, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022
Revenue	$5.566M	$5.204M	$15.35M
YoY Change	197.97%	141.26%	131.94%
Cost Of Revenue	$6.453M	$6.666M	$19.49M
YoY Change	122.36%	94.51%	82.96%
Gross Profit	-$887.0K	-$1.462M	-$4.137M
YoY Change	-14.22%	15.12%	2.58%
Gross Profit Margin	-15.94%	-28.09%	-26.95%
Selling, General & Admin	$6.982M	$5.968M	$20.71M
YoY Change	80.13%	65.69%	55.89%
% of Gross Profit
Research & Development	$10.10M	$10.23M	$35.71M
YoY Change	26.62%	48.11%	48.31%
% of Gross Profit
Depreciation & Amortization	$2.450M	$2.361M	$7.853M
YoY Change	66.33%	71.71%	68.7%
% of Gross Profit
Operating Expenses	$17.08M	$16.20M	$56.42M
YoY Change	44.13%	54.14%	51.01%
Operating Profit	-$17.97M	-$17.66M	-$60.56M
YoY Change	39.44%	49.93%	46.29%
Interest Expense	-$722.0K	-$213.0K	-$125.0K
YoY Change	-2162.86%	-765.63%	-97.15%
% of Operating Profit
Other Income/Expense, Net	-$1.182M	-$167.0K	-$472.0K
YoY Change
Pretax Income	-$19.15M	-$18.04M	-$61.03M
YoY Change	49.02%	78.21%	38.21%
Income Tax	-$57.00K	-$1.763M	-$1.833M
% Of Pretax Income
Net Earnings	-$19.09M	-$16.23M	-$59.03M
YoY Change	48.58%	60.34%	33.68%
Net Earnings / Revenue	-342.99%	-311.84%	-384.54%
Basic Earnings Per Share	-$0.33		-$1.09
Diluted Earnings Per Share	-$0.33	-$287.0K	-$1.09
COMMON SHARES
Basic Shares Outstanding	57.20M shares		54.02M shares
Diluted Shares Outstanding	57.15M shares		54.02M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$60.66M	$80.49M	$80.49M
YoY Change	-19.84%	-8.87%	-8.87%
Cash & Equivalents	$60.66M	$80.49M	$80.49M
Short-Term Investments
Other Short-Term Assets	$4.519M	$3.359M	$3.359M
YoY Change	27.76%	45.16%	45.16%
Inventory	$4.525M	$4.094M	$4.094M
Prepaid Expenses
Receivables	$2.976M	$3.793M	$3.793M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$72.68M	$91.73M	$91.73M
YoY Change	-12.03%	-1.57%	-1.57%
LONG-TERM ASSETS
Property, Plant & Equipment	$54.19M	$51.16M	$52.28M
YoY Change	45.19%	63.96%	67.57%
Goodwill	$8.051M	$8.051M
YoY Change
Intangibles	$8.639M	$8.994M
YoY Change		1472.38%
Long-Term Investments
YoY Change
Other Assets	$71.00K	$279.0K	$279.0K
YoY Change	545.45%	1016.0%	1016.0%
Total Long-Term Assets	$71.98M	$69.61M	$69.61M
YoY Change	89.94%	118.9%	118.9%
TOTAL ASSETS
Total Short-Term Assets	$72.68M	$91.73M	$91.73M
Total Long-Term Assets	$71.98M	$69.61M	$69.61M
Total Assets	$144.7M	$161.3M	$161.3M
YoY Change	20.03%	29.08%	29.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.157M	$3.630M	$3.630M
YoY Change	15.06%	205.56%	205.56%
Accrued Expenses	$7.077M	$7.887M	$7.887M
YoY Change	65.82%		30.67%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$12.65M	$12.66M	$12.66M
YoY Change	60.5%	74.23%	74.23%
LONG-TERM LIABILITIES
Long-Term Debt	$43.85M	$43.73M	$43.73M
YoY Change
Other Long-Term Liabilities	$1.472M	$1.519M	$1.519M
YoY Change	500.82%	376.18%	376.18%
Total Long-Term Liabilities	$45.33M	$45.25M	$45.25M
YoY Change	18400.41%	14084.95%	14084.95%
TOTAL LIABILITIES
Total Short-Term Liabilities	$12.65M	$12.66M	$12.66M
Total Long-Term Liabilities	$45.33M	$45.25M	$45.25M
Total Liabilities	$57.98M	$57.91M	$57.91M
YoY Change	613.45%	663.55%	663.55%
SHAREHOLDERS EQUITY
Retained Earnings	-$225.9M	-$206.8M
YoY Change		39.94%
Common Stock	$57.00K	$57.00K
YoY Change		11.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$86.69M	$103.4M	$103.4M
YoY Change
Total Liabilities & Shareholders Equity	$144.7M	$161.3M	$161.3M
YoY Change	20.03%	29.08%	29.08%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022
OPERATING ACTIVITIES
Net Income	-$19.09M	-$16.23M	-$59.03M
YoY Change	48.58%	60.34%	33.68%
Depreciation, Depletion And Amortization	$2.450M	$2.361M	$7.853M
YoY Change	66.33%	71.71%	68.7%
Cash From Operating Activities	-$14.99M	-$11.92M	-$45.20M
YoY Change	18.14%	63.23%	53.91%
INVESTING ACTIVITIES
Capital Expenditures	-$4.832M	-$13.50M	-$35.30M
YoY Change	-15.66%	427.33%	182.6%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$4.119M	$357.0K
YoY Change	-100.0%
Cash From Investing Activities	-$4.832M	-$9.386M	-$34.94M
YoY Change	-11.23%	266.5%	179.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	45.92M	$72.30M
YoY Change	-100.0%	489.58%	-15.7%
NET CHANGE
Cash From Operating Activities	-$14.99M	-11.92M	-$45.20M
Cash From Investing Activities	-$4.832M	-9.386M	-$34.94M
Cash From Financing Activities	0.000	45.92M	$72.30M
Net Change In Cash	-$19.82M	24.61M	-$7.837M
YoY Change	56.8%	-1285.65%	-117.85%
FREE CASH FLOW
Cash From Operating Activities	-$14.99M	-$11.92M	-$45.20M
Capital Expenditures	-$4.832M	-$13.50M	-$35.30M
Free Cash Flow	-$10.16M	$1.583M	-$9.896M
YoY Change	45.98%	-133.38%	-41.35%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	akts	Change In Fair Value Of Contingent Liability ChangeInFairValueOfContingentLiability		usd
CY2021Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet		usd
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1		usd
CY2021	akts	Increase Decreasein Other Long Term Liabilities IncreaseDecreaseinOtherLongTermLiabilities		usd
CY2021	us-gaap	Proceeds From Sale Of Property Held For Sale ProceedsFromSaleOfPropertyHeldForSale		usd
CY2021	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-38029
CY2022	dei	Entity Registrant Name EntityRegistrantName	AKOUSTIS TECHNOLOGIES, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	33-1229046
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	9805 Northcross Center Court
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite A
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Huntersville
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	NC
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	28078
CY2022	dei	City Area Code CityAreaCode	1-704
CY2022	dei	Local Phone Number LocalPhoneNumber	997-5735
CY2022	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
CY2022	dei	Trading Symbol TradingSymbol	AKTS
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	43731000	usd
CY2022Q2	akts	Contingent Consideration ContingentConsideration	591000	usd
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2021Q4	dei	Entity Public Float EntityPublicFloat	331100000	usd
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	57204697	shares
CY2022	dei	Auditor Firm AuditorFirmId	688
CY2022	dei	Auditor Name AuditorName	Marcum llp
CY2022	dei	Auditor Location AuditorLocation	New York
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	80485000	usd
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	88322000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3793000	usd
CY2021Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1170000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	4094000	usd
CY2021Q2	us-gaap	Inventory Net InventoryNet	1390000	usd
CY2022Q2	us-gaap	Other Assets Current OtherAssetsCurrent	3359000	usd
CY2021Q2	us-gaap	Other Assets Current OtherAssetsCurrent	2314000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	91731000	usd
CY2021Q2	us-gaap	Assets Current AssetsCurrent	93196000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	51157000	usd
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	30730000	usd
CY2022Q2	us-gaap	Goodwill Goodwill	8051000	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8994000	usd
CY2021Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	572000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1126000	usd
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	471000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	279000	usd
CY2021Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	25000	usd
CY2022Q2	us-gaap	Assets Assets	161338000	usd
CY2021Q2	us-gaap	Assets Assets	124994000	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	11204000	usd
CY2021Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	6954000	usd
CY2022Q2	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	855000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	313000	usd
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	270000	usd
CY2022Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	286000	usd
CY2021Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	41000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	12658000	usd
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	7265000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	811000	usd
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	202000	usd
CY2022Q2	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	117000	usd
CY2021Q2	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	117000	usd
CY2022Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	45250000	usd
CY2021Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	319000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	57908000	usd
CY2021Q2	us-gaap	Liabilities Liabilities	7584000	usd
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	57079347	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	57079347	shares
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	51235764	shares
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	51235764	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	57000	usd
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	51000	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	310171000	usd
CY2021Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	265130000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-206798000	usd
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-147771000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	103430000	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	117410000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	161338000	usd
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	124994000	usd
CY2022	us-gaap	Revenues Revenues	15350000	usd
CY2021	us-gaap	Revenues Revenues	6618000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	19487000	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	10651000	usd
CY2022	us-gaap	Gross Profit GrossProfit	-4137000	usd
CY2021	us-gaap	Gross Profit GrossProfit	-4033000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	35708000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	24076000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	20710000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13285000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	56418000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	37361000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-60555000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-41394000	usd
CY2022	us-gaap	Other Expenses OtherExpenses	77000	usd
CY2021	us-gaap	Other Expenses OtherExpenses	5130000	usd
CY2022	akts	Change In Fair Value Of Contingent Liability ChangeInFairValueOfContingentLiability	-347000	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1624000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	48000	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-744000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-472000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2762000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	-61027000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	-44156000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1833000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-59194000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-44156000	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-167000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-59027000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-44156000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.09
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.02
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54021205	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43426602	shares
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	41495000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	83073000	usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	25270000	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	8193000	usd
CY2021	akts	Common Stock Issued For Exercise Of Warrants CommonStockIssuedForExerciseOfWarrants	1109000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1344000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	473000	usd
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	609000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-44156000	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	117410000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	27578000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	10247000	usd
CY2022	akts	Common Stock Issued For Exercise Of Warrants CommonStockIssuedForExerciseOfWarrants	67000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	409000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	593000	usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	4162000	usd
CY2022	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	2158000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-59194000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	103430000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-59194000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-44156000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7853000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4655000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	10247000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	8192000	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	29000	usd
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4406000	usd
CY2021	akts	Non Cash Interest Payments NonCashInterestPayments	609000	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	210000	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1624000	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-744000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	271000	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	228000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	48000	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	347000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1639000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	820000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2506000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1254000	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	1241000	usd
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	905000	usd
CY2022	akts	Increase Decrease In Other Operating Asset IncreaseDecreaseInOtherOperatingAsset	12000	usd
CY2021	akts	Increase Decrease In Other Operating Asset IncreaseDecreaseInOtherOperatingAsset	-257000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2975000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1983000	usd
CY2022	akts	Iccrease Decreasein Lease Liabilities IccreaseDecreaseinLeaseLiabilities	274000	usd
CY2021	akts	Iccrease Decreasein Lease Liabilities IccreaseDecreaseinLeaseLiabilities	232000	usd
CY2022	akts	Increase Decreasein Other Long Term Liabilities IncreaseDecreaseinOtherLongTermLiabilities	1980000	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	91000	usd
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	41000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-45195000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-29364000	usd
CY2022	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	27720000	usd
CY2021	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	12440000	usd
CY2022	us-gaap	Proceeds From Sale Of Property Held For Sale ProceedsFromSaleOfPropertyHeldForSale	357000	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	7579000	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	51000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-34942000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-12491000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	27578000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	82843000	usd
CY2022	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	67000	usd
CY2021	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	1109000	usd
CY2022	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	409000	usd
CY2021	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	1344000	usd
CY2022	akts	Proceeds From Employee Stock Purchase Plan ProceedsFromEmployeeStockPurchasePlan	593000	usd
CY2021	akts	Proceeds From Employee Stock Purchase Plan ProceedsFromEmployeeStockPurchasePlan	473000	usd
CY2022	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	43654000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	72300000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	85769000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-7837000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	43914000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	88322000	usd
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	44408000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	80485000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	88322000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	112000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	325000	usd
CY2021	akts	Assets Purchased Using Common Stock AssetsPurchasedUsingCommonStock	25270000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	393000	usd
CY2021	akts	Stock Issuance Costs Included In Accounts Payable And Accrued Expenses StockIssuanceCostsIncludedInAccountsPayableAndAccruedExpenses	-230000	usd
CY2022	akts	Additiona Paid In Capital AdditionaPaidInCapital	1346000	usd
CY2022	akts	Intangibles Intangibles	9452000	usd
CY2022	us-gaap	Goodwill Transfers GoodwillTransfers	8051000	usd
CY2022	akts	Deferred Tax Liability DeferredTaxLiability	1980000	usd
CY2022	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	1099000	usd
CY2022	akts	Liabilities Assumed LiabilitiesAssumed	-1871000	usd
CY2022	akts	Issuance Of Common Stock For Acquisition IssuanceOfCommonStockForAcquisition	4162000	usd
CY2022	akts	Noncontrolling Interest NoncontrollingInterest	-2158000	usd
CY2022	akts	Revenue Expected To Be Recognized RevenueExpectedToBeRecognized	8000000	usd
CY2021Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1188000	usd
CY2022Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1956000	usd
CY2021Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	78000	usd
CY2022Q2	akts	Total Inventories TotalInventories	4094000	usd
CY2022	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 1. Organization</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Akoustis Technologies, Inc. (“the Company”) was incorporated on April 10, 2013, and effective December 15, 2016, the Company changed its state of incorporation to the State of Delaware. Through its subsidiaries, Akoustis, Inc. (a Delaware corporation) and RFM Integrated Device, Inc. (a Texas corporation) (“RFMi”), the Company, headquartered in Huntersville, North Carolina, is focused on developing, designing, and manufacturing innovative radio frequency (“RF”) filter products for the wireless industry, including for products such as smartphones and tablets, cellular infrastructure equipment, WiFi Customer Premise Equipment (“CPE”), and military and defense communication applications. Located between the device’s antenna and its digital backend, the RF front-end (“RFFE”) is the circuitry that performs the analog signal processing and contains components such as amplifiers, filters and switches. To construct the resonator devices that are the building blocks for its RF filters, the Company has developed a family of novel, high purity acoustic piezoelectric materials as well as a unique microelectromechanical system (“MEMS”) wafer process, collectively referred to as XBAW™ technology. The Company leverages its integrated device manufacturing (“IDM”) business model to develop and sell high performance RF filters using its XBAW<sup>TM</sup> technology. Filters are critical in selecting and rejecting signals, and their performance enables differentiation in the modules defining the RFFE. Additionally, through RFMi, a wholly-owned subsidiary of Akoustis, Inc., the Company makes sales of complementary SAW resonators, RF filters, crystal (Xtal) resonators and oscillators, and ceramic products branded as “RFMi” products.</p>
CY2022Q2	us-gaap	Cash Cash	80500000	usd
CY2022Q2	akts	Working Capital WorkingCapital	79500000	usd
CY2022	us-gaap	Liquidation Basis Of Accounting Remeasurement Gain Loss On Accrued Costs To Dispose Of Assets And Liabilities LiquidationBasisOfAccountingRemeasurementGainLossOnAccruedCostsToDisposeOfAssetsAndLiabilities	48000000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Use of estimates and assumptions</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date(s) of the financial statements and the reported amounts of revenues and expenses during the reporting period(s). The policies, estimates and assumptions include estimates and assumptions used in valuation of equity instruments, deferred taxes and related valuation allowances, contingent consideration, goodwill, fair value of the acquired intangible assets, initial fair value of the non-controlling interest, revenue recognition, derivative liabilities, and the fair values of long-lived assets. Actual results could differ from the estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022Q2	us-gaap	Cash Uninsured Amount CashUninsuredAmount	80500000	usd
CY2022Q2	akts	Closing Contract Liability ClosingContractLiability	286000	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-512000	usd
CY2021Q2	akts	Total Inventories TotalInventories	1390000	usd
CY2022Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1980000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	2158000	usd
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	14761000	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	245000	usd
CY2021Q2	akts	Contract Assets ContractAssets	125000	usd
CY2021Q2	akts	Closing Contract Assets ClosingContractAssets	411000	usd
CY2021Q2	akts	Closing Contract Liability ClosingContractLiability	41000	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-286000	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	41000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities	1871000	usd
CY2022	akts	Derivative Instrument Term DerivativeInstrumentTerm	P12M
CY2022Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	41000	usd
CY2022Q2	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	411000	usd
CY2022Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	1077000	usd
CY2021Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	124000	usd
CY2022Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1061000	usd
CY2022	akts	Total Revenue With Customers TotalRevenueWithCustomers	15350000	usd
CY2021	akts	Total Revenue With Customers TotalRevenueWithCustomers	6618000	usd
CY2022Q2	akts	Contract Assets ContractAssets	411000	usd
CY2022Q2	akts	Contract Liability ContractLiability	41000	usd
CY2022Q2	akts	Closing Contract Assets ClosingContractAssets	923000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	68431000	usd
CY2021Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	42029000	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	17274000	usd
CY2021Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11299000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	51157000	usd
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	30730000	usd
CY2022	us-gaap	Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1 AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1	6800000	usd
CY2021	us-gaap	Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1 AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1	4600000	usd
CY2022	us-gaap	Assets Disposed Of By Method Other Than Sale In Period Of Disposition Gain Loss On Disposition1 AssetsDisposedOfByMethodOtherThanSaleInPeriodOfDispositionGainLossOnDisposition1	14500000	usd
CY2021	us-gaap	Assets Disposed Of By Method Other Than Sale In Period Of Disposition Gain Loss On Disposition1 AssetsDisposedOfByMethodOtherThanSaleInPeriodOfDispositionGainLossOnDisposition1	4900000	usd
CY2022Q2	akts	Effect Of Exchange Rates On Cash And Cash Equivalents EffectOfExchangeRatesOnCashAndCashEquivalents	3500000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.30	pure
CY2022Q2	us-gaap	Contingent Consideration Classified As Equity Fair Value Disclosure ContingentConsiderationClassifiedAsEquityFairValueDisclosure	347000	usd
CY2022Q2	akts	Net Cash Paid NetCashPaid	9500000	usd
CY2022	akts	Business Combination Common Stock BusinessCombinationCommonStock	4162000	usd
CY2022Q2	us-gaap	Business Combination Contingent Consideration Asset Current BusinessCombinationContingentConsiderationAssetCurrent	1099000	usd
CY2022Q2	us-gaap	Business Combination Contingent Consideration Asset BusinessCombinationContingentConsiderationAsset	14761000	usd
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	1921000	usd
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther	1346000	usd
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill	9452000	usd
CY2022Q2	us-gaap	Goodwill Gross GoodwillGross	8051000	usd
CY2022	akts	Discount Rate DiscountRate	0.18	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.05	pure
CY2022	akts	Adjustment Factor Rate AdjustmentFactorRate	0.05	pure
CY2022	akts	Percentage Of Control Discount PercentageOfControlDiscount	0.167	pure
CY2022Q2	akts	Ownership Percentage OwnershipPercentage	0.51	pure
CY2022	us-gaap	Acquisition Costs AcquisitionCosts	100000	usd
CY2022	akts	Revenues Acquisition RevenuesAcquisition	5700000	usd
CY2022	akts	Loss From Operations LossFromOperations	400000	usd
CY2022	akts	Expense Expense	347000	usd
CY2022	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	17405000	usd
CY2021	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	11074000	usd
CY2022	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	59470000	usd
CY2021	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	45141000	usd
CY2022	us-gaap	Earnings Per Share Diluted Pro Forma Adjustment EarningsPerShareDilutedProFormaAdjustment	-1.09
CY2021	us-gaap	Earnings Per Share Diluted Pro Forma Adjustment EarningsPerShareDilutedProFormaAdjustment	-1.02
CY2020Q3	akts	Avg Price Per Sharein Dollars Per Share AvgPricePerShareinDollarsPerShare	8.09
CY2020Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	416221	shares
CY2022Q2	us-gaap	Goodwill Gross GoodwillGross	8100000	usd
CY2021Q2	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	6954000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	8.49
CY2022Q2	akts	Operating Leases Future Minimum Payment Due In Four Year OperatingLeasesFutureMinimumPaymentDueInFourYear	199000	usd
CY2022Q2	akts	Operating Leases Future Minimum Payment Due OperatingLeasesFutureMinimumPaymentDue	1333000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	10068000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-1074000	usd
CY2022Q2	akts	Finite Lived Intangible Asset Net FiniteLivedIntangibleAssetNet	8994000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1000000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1431000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1431000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1431000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1431000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1332000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1938000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	8994000	usd
CY2020Q3	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	3400000	usd
CY2020Q3	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	100000	usd
CY2020Q3	akts	Net Proceeds NetProceeds	3300000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3630000	usd
CY2021Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1188000	usd
CY2022Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	4641000	usd
CY2021Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	4415000	usd
CY2022Q2	akts	Accrued Goods Received Not Invoiced AccruedGoodsReceivedNotInvoiced	1472000	usd
CY2021Q2	akts	Accrued Goods Received Not Invoiced AccruedGoodsReceivedNotInvoiced	761000	usd
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1461000	usd
CY2021Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	590000	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	11204000	usd
CY2022Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	44000000	usd
CY2022Q2	akts	Debt Discount DebtDiscount	3297000	usd
CY2022Q2	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	3028000	usd
CY2022Q2	akts	Carrying Value Of Convertible Notes CarryingValueOfConvertibleNotes	43731000	usd
CY2022	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2027-06-15
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3300000	usd
CY2022Q2	us-gaap	Debt Current DebtCurrent	3000000	usd
CY2022Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	300000	usd
CY2022	akts	Contractual Interest ContractualInterest	154000	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	29000	usd
CY2020Q2	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	1600000	usd
CY2021Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1600000	usd
CY2020Q4	akts	Avg Price Per Sharein Dollars Per Share AvgPricePerShareinDollarsPerShare	8.93
CY2020Q4	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	2296023	shares
CY2020Q4	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	20500000	usd
CY2020Q4	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	400000	usd
CY2020Q4	akts	Net Proceeds NetProceeds	20100000	usd
CY2021Q3	akts	Avg Price Per Sharein Dollars Per Share AvgPricePerShareinDollarsPerShare	9.99
CY2021Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	555455	shares
CY2021Q3	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	5500000	usd
CY2021Q3	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	100000	usd
CY2021Q3	akts	Net Proceeds NetProceeds	5400000	usd
CY2021Q4	akts	Avg Price Per Sharein Dollars Per Share AvgPricePerShareinDollarsPerShare	7.04
CY2021Q4	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	1931022	shares
CY2021Q4	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	13600000	usd
CY2021Q4	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	200000	usd
CY2021Q4	akts	Net Proceeds NetProceeds	13400000	usd
CY2022Q1	akts	Avg Price Per Sharein Dollars Per Share AvgPricePerShareinDollarsPerShare	6.03
CY2022Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	1157919	shares
CY2022Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	7000000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	200000	usd
CY2022Q1	akts	Net Proceeds NetProceeds	6800000	usd
CY2022Q2	akts	Avg Price Per Sharein Dollars Per Share AvgPricePerShareinDollarsPerShare	3.88
CY2022Q2	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	533922	shares
CY2022Q2	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	2100000	usd
CY2022Q2	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	100000	usd
CY2022Q2	akts	Net Proceeds NetProceeds	2000000	usd
CY2021Q1	akts	Avg Price Per Sharein Dollars Per Share AvgPricePerShareinDollarsPerShare	14.99
CY2021Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	2082148	shares
CY2021Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	31200000	usd
CY2021Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	500000	usd
CY2021Q1	akts	Net Proceeds NetProceeds	30700000	usd
CY2021Q2	akts	Avg Price Per Sharein Dollars Per Share AvgPricePerShareinDollarsPerShare	10.01
CY2021Q2	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	762197	shares
CY2021Q2	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	7600000	usd
CY2021Q2	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	100000	usd
CY2021Q2	akts	Net Proceeds NetProceeds	7500000	usd
CY2021Q1	akts	Purchase Agreement Shares PurchaseAgreementShares	1500000	shares
CY2021Q1	akts	Purchase Price PurchasePrice	14.3592	usd
CY2021Q1	akts	Aggregate Gross Proceeds AggregateGrossProceeds	21500000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2497577	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.49
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	712300	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	8.49
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	87263	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	4.69
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	102612	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	8.55
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3020002	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.95
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y2M12D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	286000	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1707578	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	5.94
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y1M9D
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	286000	usd
CY2022	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	-1982000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1833000	usd
CY2022	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	5586000	usd
CY2021	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	4037000	usd
CY2022	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	4661000	usd
CY2021	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	4155000	usd
CY2022	akts	Share Based Compensations ShareBasedCompensations	10247000	usd
CY2021	akts	Share Based Compensations ShareBasedCompensations	8192000	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	348000	usd
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	310000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1126000	usd
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	313000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	811000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	45492000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	33699000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y5M1D
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1003	pure
CY2022	akts	Future Lease Payments Term FutureLeasePaymentsTerm	P5Y
CY2022Q2	akts	Operating Leases Future Minimum Payment Due Current OperatingLeasesFutureMinimumPaymentDueCurrent	412000	usd
CY2022Q2	akts	Operating Leases Future Minimum Payment Due In Two Years OperatingLeasesFutureMinimumPaymentDueInTwoYears	366000	usd
CY2022Q2	akts	Operating Leases Future Minimum Payment Due In Three Years OperatingLeasesFutureMinimumPaymentDueInThreeYears	357000	usd
CY2022Q2	akts	Lessee Operating Leases Liability Undiscounted Excess Amount LesseeOperatingLeasesLiabilityUndiscountedExcessAmount	-208000	usd
CY2022Q2	akts	Lessee Operating Leases Liability Payments Due LesseeOperatingLeasesLiabilityPaymentsDue	1125000	usd
CY2018Q1	akts	Ontario County Industrial Development Authority Agreement Description OntarioCountyIndustrialDevelopmentAuthorityAgreementDescription	Pursuant to the Agreements, the Company will lease for $1.00 annually to the OCIDA an approximately 9.995 acre parcel of land in Canandaigua, New York, together with the improvements thereon (including the Company’s New York fabrication facility), and transfer title to certain related equipment and personal property to the OCIDA (collectively, the “Facility”).
CY2022	akts	Tax Savings Agreement Expire Date TaxSavingsAgreementExpireDate	December 31, 2028
CY2018Q1	akts	Aggregate Principal Amount AggregatePrincipalAmount	12000000	usd
CY2022	akts	Payments For Lease Benefits PaymentsForLeaseBenefits	300000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	134000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	15000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	149000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-2000000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	18000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.0029	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.0015	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.0149	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.0215	pure
CY2022	akts	Stockbased Compensation StockbasedCompensation	0.0028	pure
CY2021	akts	Stockbased Compensation StockbasedCompensation	-0.013	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Other EffectiveIncomeTaxRateReconciliationTaxCreditsOther	0.0014	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Other EffectiveIncomeTaxRateReconciliationTaxCreditsOther	-0.003	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.1932	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.2492	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.0004	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.0002	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.03	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2021Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	326000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	47031000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	32688000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3680000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2804000	usd
CY2022Q2	akts	Deferred Tax Assets Tax Credit DeferredTaxAssetsTaxCredit	2725000	usd
CY2021Q2	akts	Deferred Tax Assets Tax Credit DeferredTaxAssetsTaxCredit	1817000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1022000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1010000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	54458000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	38319000	usd
CY2022Q2	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	-1808000	usd
CY2022Q2	akts	Deferred Tax Liabilities Deferred Expense Accumulated Depreciationbasis Differences DeferredTaxLiabilitiesDeferredExpenseAccumulatedDepreciationbasisDifferences	7158000	usd
CY2021Q2	akts	Deferred Tax Liabilities Deferred Expense Accumulated Depreciationbasis Differences DeferredTaxLiabilitiesDeferredExpenseAccumulatedDepreciationbasisDifferences	4620000	usd
CY2022Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	8966000	usd
CY2021Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	4620000	usd
CY2022	akts	Assets Purchased Using Common Stock AssetsPurchasedUsingCommonStock		usd
CY2022	akts	Federal Loss Carryovers Description FederalLossCarryoversDescription	federal loss carryovers of approximately $34.2 million that will expire in stages beginning in 2034 if unused and federal loss carryovers of $182.8 million that will carry forward indefinitely. The North Carolina, New York, California and Florida state loss carryovers of approximately $28.7 million, $11.5, $12.7 and $0.05 million, respectively, will begin to expire in 2029 if unused. Federal research credits of $2.7 million will expire beginning in 2034 if not utilized.
CY2022Q2	akts	Net Change In Valuation Allowance NetChangeInValuationAllowance	11800000	usd
CY2020Q2	akts	Gross Unrecognized Tax Benefits GrossUnrecognizedTaxBenefits	400000	usd
CY2021Q2	akts	Gross Unrecognized Tax Benefits GrossUnrecognizedTaxBenefits	300000	usd
CY2022Q2	akts	Amounts Of Unrecognized Tax Benefit AmountsOfUnrecognizedTaxBenefit	400000	usd
CY2021Q2	akts	Amounts Of Unrecognized Tax Benefit AmountsOfUnrecognizedTaxBenefit	300000	usd
CY2021Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	326000	usd
CY2020Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	200000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	80000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	60000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	21000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	66000	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	427000	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	427000	usd
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	pure
CY2021Q4	akts	Fair Value Measurement Of Revenue Volatility FairValueMeasurementOfRevenueVolatility	0.30	pure
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2022	akts	Total Common Stock Equivalents Shares TotalCommonStockEquivalentsShares	12402930	shares
CY2021	akts	Total Common Stock Equivalents Shares TotalCommonStockEquivalentsShares	2664686	shares
CY2022Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	1446000	usd
CY2022Q2	us-gaap	Derivative Instruments And Hedges Liabilities DerivativeInstrumentsAndHedgesLiabilities	3028000	usd
CY2022Q2	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	4474000	usd
CY2022	akts	Initial Fair Value Of Contingent Consideration InitialFairValueOfContingentConsideration	1099000	usd
CY2022	us-gaap	Asset At Fair Value Changes In Fair Value Resulting From Changes In Assumptions AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions	347000	usd
CY2022Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	1446000	usd
CY2022	akts	Fair Value Measurement Of Revenue Volatility FairValueMeasurementOfRevenueVolatility	0.30	pure
CY2022	akts	Initial Fair Value Of Make Whole Provision In Convertible Note InitialFairValueOfMakeWholeProvisionInConvertibleNote	2647000	usd
CY2022Q2	akts	Initial Fair Value Of Change In Control Provision In Convertible Note InitialFairValueOfChangeInControlProvisionInConvertibleNote	333000	usd
CY2022Q2	akts	Change In Fair Value Of Convertible Note Derivatives ChangeInFairValueOfConvertibleNoteDerivatives	48000	usd
CY2022Q2	akts	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisAssetValue	3028000	usd
CY2022Q2	us-gaap	Share Price SharePrice	3700
CY2022Q2	us-gaap	Share Price SharePrice	4080.00
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.70	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.70	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0301	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0307	pure
CY2022	akts	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Measurements Expected Debt Yield ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueMeasurementsExpectedDebtYield	0.415	pure
CY2022	akts	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Measurements Expected Debt Yield ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueMeasurementsExpectedDebtYield	0.40	pure
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2021Q2	us-gaap	Goodwill Goodwill		usd
CY2021Q2	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent		usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	akts	Non Cash Interest Payments NonCashInterestPayments		usd
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2021	akts	Current Assets Excluding Cash And Cash Equivalents CurrentAssetsExcludingCashAndCashEquivalents		usd
CY2021	akts	Additiona Paid In Capital AdditionaPaidInCapital		usd
CY2021	akts	Intangibles Intangibles		usd
CY2021	us-gaap	Goodwill Transfers GoodwillTransfers		usd
CY2021	akts	Deferred Tax Liability DeferredTaxLiability		usd
CY2021	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1		usd
CY2021	akts	Liabilities Assumed LiabilitiesAssumed		usd
CY2021	akts	Issuance Of Common Stock For Acquisition IssuanceOfCommonStockForAcquisition		usd
CY2021Q2	akts	Contract Liability ContractLiability		usd
CY2022Q2	akts	Operating Leases Future Minimum Payment Due Thereafter OperatingLeasesFutureMinimumPaymentDueThereafter		usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit		usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2021Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions		usd
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions		usd
CY2022	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations		usd
CY2021	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations		usd
CY2021Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue		usd
CY2021Q2	akts	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisAssetValue		usd
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001584754

Files In Submission

Name	View Source	Status
0001213900-22-055194-index-headers.html	Edgar Link	pending
0001213900-22-055194-index.html	Edgar Link	pending
0001213900-22-055194.txt	Edgar Link	pending
0001213900-22-055194-xbrl.zip	Edgar Link	pending
akts-20220630.xsd	Edgar Link	pending
ex10-16_001.jpg	Edgar Link	pending
ex10-16_002.jpg	Edgar Link	pending
f10k2022ex10-14_akoustistec.htm	Edgar Link	pending
f10k2022ex10-15_akoustistec.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
f10k2022ex10-16_akoustistec.htm	Edgar Link	pending
f10k2022ex10-8ii_akoustistec.htm	Edgar Link	pending
f10k2022ex10-8i_akoustistec.htm	Edgar Link	pending
f10k2022ex21-1_akoustistec.htm	Edgar Link	pending
f10k2022ex23-1_akoustistec.htm	Edgar Link	pending
f10k2022ex31-1_akoustistec.htm	Edgar Link	pending
f10k2022ex31-2_akoustistec.htm	Edgar Link	pending
f10k2022ex32-1_akoustistec.htm	Edgar Link	pending
f10k2022ex32-2_akoustistec.htm	Edgar Link	pending
f10k2022_akoustistech.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img_001.jpg	Edgar Link	pending
img_002.jpg	Edgar Link	pending
img_003.jpg	Edgar Link	pending
img_004.jpg	Edgar Link	pending
img_005.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
akts-20220630_def.xml	Edgar Link	unprocessable
akts-20220630_pre.xml	Edgar Link	unprocessable
akts-20220630_lab.xml	Edgar Link	unprocessable
f10k2022_akoustistech_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
akts-20220630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AKTSQ
Akoustis Technologies, Inc. Stock $aktsq

2022 Q3 Form 10-K Financial Statement

#000121390022055194 Filed on September 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AKTSQ Akoustis Technologies, Inc. Stock $aktsq

2022 Q3 Form 10-K Financial Statement

#000121390022055194 Filed on September 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AKTSQ
Akoustis Technologies, Inc. Stock $aktsq